Search results
MilliporeSigma Announces Siren Biotechnology As Winner Of Its North American Advance Biotech Grant
BioresearchOnline· 2 days agoThe biotechnology startup, which is headquartered in San Francisco, California, USA, was selected...
Investing in India after the elections? The pros like these sectors and stocks
CNBC· 10 hours agoThe shock outcome of India's elections has raised questions about where investment opportunities...
African tech startups cater to continent's needs
Alaska Superstation· 6 days agoAfrican startups, addressing overlooked needs, are putting the spotlight on a burgeoning tech scene, despite challenges like inequality and limited...
Biotech company Vilya lands cash for disease-fighting 'macrocycles' - Puget Sound Business Journal
The Business Journals· 1 day agoVilya Inc., a biotech startup based Seattle and with operations in South San Francisco, California,...
Ishpeming achieves MEDC’s Redevelopment status
The Mining Journal· 6 days agoPictured are Myconaut co-founders Joe Lane, left, and Ryan Iacovacci. MARQUETTE — Myconaut, a biotechnology startup located in Marquette has secured a...
U.S. Venture Capital and Private Equity Funds Continue to Invest in China Despite the Heightened...
Digital Journal· 6 days agoContact: media@futureunion.co Andrew King www.futureunion.com SOURCE: Future Union View the original press release on accesswire.com ACCESSWIRE News network reaching more ...
The Opaque Investment Empire Making OpenAI’s Sam Altman Rich
The Wall Street Journal· 3 days agoMany companies backed by the CEO do business with the ChatGPT maker and benefit from the AI boom...
Why Ford spent $1 billion to transform an abandoned Detroit train station
Fast Company Magazine· 2 days agoBill Ford Jr., the executive chairman of the Ford Motor Company, is sitting in what was once one of...
China's new plan to dominate the future of tech will reshape the world
Business Insider· 4 days agoChina's national tech champions have joined the fray and managed to twist a technology that feeds on...
Eli Lilly adds ALS drug prospect with QurAlis deal
BioPharma Dive via Yahoo Finance· 3 days agoThe alliance hands Lilly an RNA-based therapy in preclinical testing for ALS and frontotemporal dementia, and includes a research collaboration to...